Literature DB >> 25451013

Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.

Jin-Gyun Lee1, Kimberly Q McKinney1, Antonis J Pavlopoulos1, Jeong-Hill Park2, Sunil Hwang3.   

Abstract

Therapeutic strategies for cancer treatment often remain challenging due to the cumulative risk derived from metastasis, which has been described as an aggressive state of cancer cell proliferation often resulting in failure of clinical therapy. In the current study, anti-metastatic properties of three chemotherapeutic drugs and three compounds from natural sources were investigated by comparative proteomic analysis. Proteomic profile comparison of the isogenic primary and metastatic colon cancer cell lines SW480 and SW620 identified two potential metastasis related molecular targets: fatty acid synthase and histone H4. To demonstrate their biological roles in cancer metastasis, the expression of these target genes was suppressed by siRNA transfection. Subsequent cell migration assays demonstrated reduced migratory effects. SW620 cells were treated with six anti-cancerous components. Through comprehensive proteomic analysis, three of the tested compounds, oxaliplatin, ginsenoside 20(S)-Rg3 and curcumin, were revealed to have a suppressive effect on FASN and histone H4 expression. SW620 cells treated with these drugs showed significantly reduced migratory activity, which suggests that drug-induced targeted suppression of these genes may affect cell migration. The validity of the proteomic datasets was verified by knowledgebase pathway analysis and immunoblotting assays. The anti-metastatic components revealed by the current proteomic analysis represent promising chemotherapeutic candidates for the treatment of colorectal adenocarcinoma. BIOLOGICAL SIGNIFICANCE: The current study demonstrates anti-metastatic activity of chemotherapeutics and natural components by the suppression of target molecules, fatty acid synthase and histone H4 identified by a comparative proteomic analysis employing the isogenic primary and metastatic colon cancer cell lines, SW480 and SW620. Three tested drugs, namely, oxaliplatin, ginsenoside 20(S)-Rg3 and curcumin were revealed to possess suppressive effects on fatty acid synthase and histone H4 and reduce metastasis as determined by cell migration assay. Data were confirmed by the correlation between spectral counts from proteomic data and Western blot analysis, which were in good agreement with immunohistochemistry.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell migration; Colorectal adenocarcinoma; Fatty acid synthase; Histone H4; Metastasis; Natural compound

Mesh:

Substances:

Year:  2014        PMID: 25451013     DOI: 10.1016/j.jprot.2014.10.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  5 in total

1.  Total ginsenosides of Chinese ginseng induces cell cycle arrest and apoptosis in colorectal carcinoma HT-29 cells.

Authors:  Ting Li; Wan Sun; Xiaoqiao Dong; Wenhua Yu; Jianyong Cai; Qiang Yuan; Letian Shan; Thomas Efferth
Journal:  Oncol Lett       Date:  2018-07-23       Impact factor: 2.967

2.  Targeted Quantitative Proteomic Approach for Probing Altered Protein Expression of Small GTPases Associated with Colorectal Cancer Metastasis.

Authors:  Ming Huang; Yinsheng Wang
Journal:  Anal Chem       Date:  2019-04-12       Impact factor: 6.986

3.  Co-treatment with Ginsenoside 20(S)-Rg3 and Curcumin increases Radiosensitivity of MDA-MB-231 Cancer Cell Line.

Authors:  Vahid Changizi; Vahideh Gharekhani; Elaheh Motavaseli
Journal:  Iran J Med Sci       Date:  2021-07

4.  Data supporting the identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.

Authors:  Jin-Gyun Lee; Kimberly Q McKinney; Antonis J Pavlopoulos; Jeong-Hill Park; Sunil Hwang
Journal:  Data Brief       Date:  2014-11-04

5.  Carvacrol alters soluble factors in HCT-116 and HT-29 cell lines

Authors:  Ahu Pakdemirli; Caner Karaca; Tolga Sever; Ezgi Daşkin; Asim Leblebici; Türkan Yiğitbaşi; Yasemin Başbinar
Journal:  Turk J Med Sci       Date:  2020-02-13       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.